Loss of the tumor suppressor PML in human cancers of multiple histologic origins. - Wikidata - awgldk - TriplyDB

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

http://www.wikidata.org/entity/Q34299352

about

PML nuclear bodies Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation PML bodies control the nuclear dynamics and function of the CHFR mitotic checkpoint protein The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA The mechanisms of PML-nuclear body formation PMLRARα binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivo Promyelocytic leukemia protein interacts with the apoptosis-associated speck-like protein to limit inflammasome activation The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic Implications Cul3-KLHL20 ubiquitin ligase: physiological functions, stress responses, and disease implications The function, regulation and therapeutic implications of the tumor suppressor protein, PML The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival Prolyl isomerase Pin1 in cancer Stress responses from the endoplasmic reticulum in cancer Cytoplasmic PML function in TGF-beta signalling The role of T‑box genes in the tumorigenesis and progression of cancer (Review)PML regulates apoptosis at endoplasmic reticulum by modulating calcium release Adenovirus type 5 early region 1B 55K oncoprotein-dependent degradation of cellular factor Daxx is required for efficient transformation of primary rodent cells PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon?Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies Functional connection between Rad51 and PML in homology-directed repair.Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.Promyelocytic leukemia protein controls cell migration in response to hydrogen peroxide and insulin-like growth factor-1 Dysregulation of promyelocytic leukemia (PML) protein expression in preeclamptic placentae.The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.Loss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes.Impact of nuclear organization and dynamics on epigenetic regulation in the central nervous system: implications for neurological disease states.Deficiency of the promyelocytic leukemia protein fosters hepatitis C-associated hepatocarcinogenesis in mice PML targeting eradicates quiescent leukaemia-initiating cells.Markers of bile duct tumors A Role for PML in Innate Immunity Nuclear domain 10 of the viral aspect.

P2860

Q22065791-E8791836-1081-4490-A580-B4BDAE75AFA6 Q24293467-57860AF1-8CC4-42A3-A21F-6A875C6C9836 Q24297944-2FF7CFDF-6522-490A-88E4-173550311461 Q24300018-22A21A3F-EA97-47FB-BB25-ED9AE325C2B3 Q24306227-77E3715A-B98F-4AD3-911D-EE89B172E1E2 Q24306346-0D39BE4F-83E9-453E-83FE-B0996C27C155 Q24307375-63CE784B-41C9-4798-9B03-E30108DD97EC Q24311595-50E10C8E-D26B-4B78-8B50-CD0A882DB44A Q24317781-BE00466D-670C-4D06-BE59-328D0D700358 Q24318667-1A360C4C-D1E3-49E0-A3FE-B45C01D90D2F Q24337110-574FE2C2-B044-42BA-8989-A919300D98FE Q24338701-EF37343F-DD30-470E-8CDB-C89601A5BDD8 Q24338995-D8BF4C33-3A54-4881-B613-0B95D422499C Q26738747-93C988A1-D0F0-4A79-9780-08D75E3FEA8A Q26747274-6D10AC47-13D8-418A-8A11-651D02C1E65B Q26752753-26D6EAEE-AB31-4D9D-BDBC-3B558E769160 Q26779358-6AD7F127-7B6C-4609-BF7A-323B7EE68089 Q26853348-27CC5B5E-4F00-4036-9FCD-F00DC6AFEB88 Q27003831-8F7685A9-C798-4A2A-9863-89782304A371 Q27024695-F587CD19-E5DB-49BE-A3FA-9557DEFC3918 Q28082709-C70214EB-B1EC-4C58-AC63-7D1E4E7683D1 Q28281152-FA2CDC9B-A460-42B1-A26B-6F044D947F8D Q28468370-4AE0E182-3CD3-4566-83B0-B8023C8EA6DA Q28508184-CD30B955-15C9-49A7-828A-A355057F45E1 Q28574947-A7A80617-046E-4CBA-966C-2EBB8CAFE760 Q28590200-D4AD7CA7-E91A-43A6-805B-82FDC0148ECA Q28755220-AE694007-5135-40C4-8820-CF2DE0C0A617 Q30845046-AE55B9B0-FA99-4551-AA11-C5876F7E09EA Q31037336-9A1CAB67-2368-406D-83A6-3B349D902E2C Q33373662-41D9301C-03FE-4AE1-9D44-BF7C608F4131 Q33744538-2FA901F6-F0BB-4C76-A062-BC57684E185C Q33801203-A9EC3298-DF5B-4160-8E28-3001F891F014 Q33815705-44420E49-4E3D-48B5-BBD4-DD1D4F52BAFF Q34056212-AEB51A88-2E60-4D33-82AE-04F9F5B21F10 Q34157417-2D3C2CE5-EF19-4051-8966-A60D134971FD Q34415922-461D248B-CCE0-4E64-8AF9-9A8FC483618A Q34591761-B4767605-DC41-48BC-BD99-181E56C3E85C Q34628852-1F04890B-B492-4FEE-B0B1-5FC425D494D3 Q35034064-2111F503-940D-4C6A-B1A3-169192443DC0 Q35047491-93D90004-C030-4C2A-90E9-D170ACF845F1

P2860

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

http://www.wikidata.org/entity/Q34299352

description

2004 nî lūn-bûn

@nan

2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

@ast

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

@en

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

@nl

type

label

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

@ast

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

@en

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

@nl

prefLabel

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

@ast

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

@en

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

@nl

P1433

Q34299352-E8961E50-724D-41B6-A82A-5308505659A4

P1476

Q34299352-6485B0CA-DE2C-44B0-BE59-10205B3240D9

P2093

Q34299352-070CF63F-E5A4-4087-8FCD-F21F61479FEF

Q34299352-3C327F6C-F42F-498E-AF81-5337E890568B

Q34299352-5C26419B-4D7A-4CA4-BD75-286B3611F74C

Q34299352-E13C28AF-9CA6-4941-8BCB-5691A1716F9A

Q34299352-F72DD1F2-1015-484E-92E2-BEF370A0222B

Q34299352-FAEEC67A-BFE3-413B-9AE7-CA9408176925

Q34299352-FD6596CB-D0FF-4757-B422-756C8A5D0780

P304

Q34299352-AD7BC231-49FC-48E9-9C31-E4EE4E0A9141

P31

Q34299352-E04D62BD-EE3A-48B6-A15D-A2EB69B45902

P356

Q34299352-F2D7F539-4AE2-4E3A-A0A2-128F0B7B5E0C

P407

Q34299352-BAC029AA-61F3-4F5D-8A43-24BA8E601233

P433

Q34299352-AC938431-D2E6-4F46-8941-D6C7963FE3D7

P478

Q34299352-32E1040F-1528-4507-B7D0-E95EB053A98C

P50

Q34299352-1841B720-76AC-406F-A8AF-4A8D56BADD27

Q34299352-D1C8B125-4C08-4ACB-8F54-FF6C0CE772B5

P577

Q34299352-847FA535-8793-4EB3-A6C6-87C3028A20A6

P5875

Q34299352-7F12E529-B2D9-473B-A21C-FA80B7396066

P698

Q34299352-962F807E-AA01-4AE6-897A-F2AA21211F05

P356

P1433

Journal of the National Cancer Institute

P1476

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

@en

P2093

Carmela Gurrieri

http://www.w3.org/2001/XMLSchema#string

David A Verbel

http://www.w3.org/2001/XMLSchema#string

Khedoudja Nafa

http://www.w3.org/2001/XMLSchema#string

Laura J Rush

http://www.w3.org/2001/XMLSchema#string

Paola Capodieci

http://www.w3.org/2001/XMLSchema#string

Pier Paolo Scaglioni

http://www.w3.org/2001/XMLSchema#string

Rosa Bernardi

http://www.w3.org/2001/XMLSchema#string

P304

269-279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJH043

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Cordon-Cardo

Pier Paolo Pandolfi

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5783582

http://www.w3.org/2001/XMLSchema#string

P698

14970276

http://www.w3.org/2001/XMLSchema#string